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In the present study, we demonstrate for the first time that h-adrenergic agonists stimulate bone-resorbing activity in human osteoclast-like
multinucleated cells (MNCs). Osteoclast-like MNCs constitutively expressed mRNA for a1B-, a2B- and h2-adrenergic receptor (AR) in
addition to characteristic markers of mature osteoclast, such as calcitonin receptor (CT-R), tartrate-resistant acid phosphatase (TRAP), aV-
chain of integrin (Int aV), carbonic anhydrase II (CA-II) and cathepsin K (Cathe K). Epinephrine (1 AM; a,h-adrenergic agonist) up-
regulated expression of Int aV, CA-II and Cathe K in the osteoclast-like MNCs. Osteoclastic resorbing activity was markedly increased by
isoprenaline (1 AM; h-adrenergic agonist), moderately by epinephrine, but poorly by phenylephrine (1 AM; a1-adrenergic agonist). The actin
ring, which was suggested to be correlated with bone-resorbing activity, was clearly observed in osteoclast-like MNCs treated with
isoprenaline and epinephrine, but faintly in those treated with phenylephrine. These findings suggest that h-adrenergic agonists directly
stimulate bone-resorbing activity in matured osteoclasts.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Osteoclast; Bone-resorbing activity; Epinephrine; Isoprenaline; h-Adrenergic agonist1. Introduction
Immunohistochemical studies showed that mammalian
bones were widely innervated by sympathetic and sensory
nerves [1,2]. We recently demonstrated the constitutive
expression of axon guidance molecules, which are known
to be chemoattractant or chemorepellent for growing nerve
fibers, in osteoblastic and osteoclastic cells, suggesting the
extension of axons of peripheral neurons to osteoblastic and
osteoclastic cells and the possible neural regulation of bone
metabolism in these osteogenic cells [3]. The possibility of
adrenergic regulation in bone resorption has been docu-
mented in in vivo and in vitro studies. It was demonstrated
that chemical sympathectomy by guanethidine-impaired
bone resorption in rats [4], and that h-adrenergic agonists0167-4889/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
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E-mail address: togariaf@dpc.aichi-gakuin.ac.jp (A. Togari).could stimulate bone resorption in intact mouse calvariae [5]
and production of prostaglandin E2 (PGE2), a bone-resorp-
tion factor, in mouse osteoblastic cells [6].
Osteoclasts are multinucleated cells (MNCs) that are
responsible for bone resorption [7]. The molecular basis
for the regulation of osteoclast formation and function by
cells of the osteoblastic lineage has been identified; osteo-
blastic cells induced osteoclastic differentiation and resorb-
ing activity through expression of osteoclast differentiation
factor (ODF, also known as RANKL/OPGL/TRANCE) [8].
In our recent study, we showed that isoprenaline and
epinephrine increased ODF/RANKL mRNA expression in
mouse osteoblastic cell line MC3T3-E1, and induced osteo-
clastogenesis in mouse bone marrow culture, suggesting h-
adrenergic stimulation of bone resorption via osteoblastic
cells [9]. However, there remains a possible mechanism for
the stimulative effect of h-adrenergic agonist on osteoclasts.
Frediani et al. [10] demonstrated that cathecolamines may
act as inducers of osteoclast maturation in vitro and as
stimulators of osteoclast activity via binding to h2-AR byed.
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(FLG 29.1 cells).
In the present study, using human osteoclast-like MNCs,
we examined if adrenergic stimulation could directly acti-
vate the osteoclastic function.2. Materials and methods
2.1. Materials
Epinephrine bitartrate, phenylephrine hydrochloride, iso-
prenaline bitartrate and pronase E were purchased from
Sigma (St. Louis, MO). Heat-inactivated horse serum and
a-minimum essential medium (a-MEM) were purchased
from Gibco BRL (Life Technologies, Grand Island, NY).
All other chemicals used were of reagent grade.
2.2. Isolation of human osteoclast-like MNCs
Human osteoclast-like MNCs were generated using
bone marrow, which was obtained as surgical waste from
elderly patients, who gave their informed consent before
artificial hip replacement surgery. Briefly, the mononu-
clear cells were separated by density gradients centrifu-
gation (400 g, 30 min) through Histopaque 1077
(Sigma) and were resuspended in a-MEM supplemented
with 20% heat-inactivated horse serum and 10 nM
1a,25(OH)2D3 at a final concentration of 5 106 cells/
ml; 2 ml of cell suspension was seeded in 35-mm plastic
dishes and cultured at 37 jC in humidified air with 5%
CO2. When the numbers of osteoclast-like MNCs ap-
peared in the culture about 2 weeks after the start of
primary cultures, stromal cells and other cells that had
adhered to the osteoclast-like MNCs were selectively
removed by treatment with 0.002% pronase E and
0.02% EDTA for 5 min with agitation, as reportedTable 1
Nucleotide of PCR primers
Sense Antisens
a1A-AR GTGCGCCTGCTCAAGTTCTCC TCGGG
a1B-AR TGGGCGCCTTCATCCTCTTTG CGCAC
a1D-AR TCTTTTCGGGGTGCTGGGTAA TGGGT
a2A-AR TCGTCATCATCGCCGTGTTCA GCCGC
a2B-AR GGGAGACCCCTGAAGATACTG ACAAA
a2C-AR GCGGCAGGCGAGGCGAGAACG AACCA
h1-AR GCCATCGCCTCGTCCGTAGTC CGTAG
h2-AR TCTGATGGTGTGGATTGTGTC ACGTC
h3-AR CCCAATACCGCCAACACCAGT CGACC
TRAP CTTCAAGATCCCACAGACCAA ATTCCC
CT-R CTGCTGGCTGAGTGTGGAAAC GATTC
CAII GAGGATCCTCAACAATGGTCA GAAGA
Int aV CTTCTTGGTGGTCCTGGTAGC CACAT
Cathe K CAAGAAGAAAACTGGCAAACT TGTAA
GAPDH ACCACAGTCCATGCCATCAC TCCAC
AR, adrenergic receptor; TRAP, tartrate-resistant acid phosphatase; CT-R, calcitoni
K, cathepsin K; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.previously [11]. Greater than 95% of the remaining cells
were osteoclast-like MNCs.
2.3. RNA extraction and RT-PCR procedures
RNA was extracted by the guanidium-thiocyanate
method [12]. RT-PCR was performed using standard meth-
ods, as reported previously [13]. Briefly, cDNA was first
synthesized using random primers and Moloney murine
leukemia virus reverse transcriptase (Gibco-BRL), followed
by PCR amplification using specific primers. The oligonu-
cleotides used as primers for PCR are shown in Table 1
[14–28]. PCR amplification was performed using the
GeneAmp PCR System (Perkin Elmer/Cetus, Norwalk,
CT) as follows: denaturation at 95 jC for 15 s, annealing
at 55 jC for 30 s and elongation at 72 jC for 30 s for
appropriate cycles. PCR products were electrophoresed on a
2% Nusieve agarose gel (FMC BioProducts, Rockland, ME)
and stained with ethidium bromide and detected on a
FluorImager 575 (Molecular Dynamics, Sunnyvale, CA).
2.4. Formation of resorption pits on calcium phosphate-
coated disk
Bone-resorption activity of osteoclast-like MNCs was
examined by the simple testing method using calcium phos-
phate-coated disks with culture wells (Osteologic; Millenium
Biologix, Ontario, Canada) [29]. After osteoclast-like MNCs
were dispersed with agitation in pronase E solution for 20
min, cells were reseeded onto calcium phosphate-coated
disks and cultured in a-MEM with phenylephrine (1 AM),
epinephrine (1 AM) and isoprenaline (1 AM) for 5 days. The
culture medium containing each drug was replaced every 2
days. The culture was terminated on day 5 by the addition of
6% sodium hypochlorite to remove cells. Calcium phosphate-
coated disks were stained with 5% silver nitrite for 2 h, fixed
in 10% formalin containing 5% sodium carbonate, ande Size (bp) Reference
CGTTCCTGGGGGTTCG (434) [14]
TCCTTGTCATCGTTGG (432) [15]
GACGATGGTTGGGTAG (309) [16]
CGCCGCCCTTCTTCTC (380) [17]
AACGCCAATGACCACA (367) [18]
GCAGAGCACGAACACG (386) [19]
CCCAGCCAGTTGAAGA (430) [20]
TTGAGGGCTTTGTGCT (362) [21]
CACACCAGGACCACAG (427) [22]
AGCCCCACTCAGCAC (367) [23]
ATTTCCAGGGCTTCTT (294) [24]
GGAGGGGTGGTCAGTG (437) [25]
CTGCATAATCATCTCC (372) [26]
AACTGGAAGGAGGTCA (323) [27]
CACCCTGTTGCTGTA (452) [28]
n receptor; CAII, carbonic anhydrase II; Int aV, aV-chain of integrin; Cathe
Fig. 1. Expression of mRNA for characteristic markers of mature
osteoclasts (A) and adrenergic receptor phenotypes (B). (A) Total RNA
extracted from human osteoclast-like MNCs was assayed by RT-PCR using
specific primers for TRAP, CT-R, CAII, Int aV, Cathe K and GAPDH. (B)
Total RNA from MNCs was assayed by RT-PCR using specific primers
for a1A-AR, a1B-AR, a1D-AR, a2A-AR, a2B-A, a2C-AR, h1-AR, h2-
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estimated from the pit area measured by counting the mesh
number inside the pit on the microscopic photograph.
2.5. Formation of actin ring in osteoclast-like MNCs
Osteoclast-like MNCs were seeded onto the cover glass,
which was placed on the bottom of the plastic dishes and
cultured in a-MEM with phenylephrine (1 AM), epinephrine
(1 AM) and isoprenaline (1 AM) for 24 h. At the end of the
experiment, cells were fixed with 10% formalin in phos-
phate buffered saline (PBS) for 10 min at room temperature,
and then permeabilized with 0.1% Triton X-100 for 5 min.
After washing in PBS, F-actin in the osteoclast-like MNCs
was stained with 0.3 AM rhodamine-conjugated phalloidine
for 60 min at room temperature. The formation of ringed
structure of F-actin was observed under a fluorescence
microscope.AR, h3-AR and GAPDH. GAPDH is a housekeeping gene for internal
standard. DNA size markers (fX174/HaeIII digest) are shown on the left
lane (S). Numbers in parentheses on the top of lane indicate cycles of PCR
amplification.
3. Results and discussion
3.1. Expression of mRNA for adrenergic receptor (AR)
subtypes in osteoclast-like MNCs
The human osteoclast-like MNCs used in this study were
formed from human bone marrow. The human osteoclast-
like MNCs fulfilled the functional criteria of osteoclasts:
expression of tartrate-resistant acid phosphatase (TRAP);
binding of 125I-labeled calcitonin; formation of resorption
pits on calcium phosphate-coated materials and bovine
bone; and calcitonin-induced inhibition of resorbing activity
[29]. As shown in Fig. 1, the steady state of osteoclast-like
MNCs expressed not only mRNA for characteristics of
mature osteoclast, such as TRAP, calcitonin receptor (CT-
R), carbonic anhydrase II (CA II), aV-chain of integrin (Int
aV) and cathepsin K (Cathe K) (Fig. 1A) but also mRNA
for AR subtypes, such as a1B-AR, a2B-AR and h2-AR
(Fig. 1B). However, expressions of a1A-AR, a1D-AR,
a2A-AR, a2C-AR, h1-AR and h3-AR were not observed.
These findings suggested that osteoclast-like MNCs were
regarded as mature osteoclastic cells and equipped with an
ability to receive adrenergic stimulation.
3.2. Effect of epinephrine on mRNA levels for characteristic
markers of bone-resorbing function in osteoclast-like MNCs
As characteristic markers for osteoclasts, CA II, Int aV
and Cathe K were suggested to be essential for the bone-
resorbing function [7]. CAII catalyzes protons from CO2
and water to demineralize bone, avh3 integrin localized at
the osteoclastic cell surface contributes to the osteoclast’s
attachment to the bone surface, and Cathe K, a lysosomal
cysteine protease specifically produced in osteoclasts, is
considered to degrade type I collagen of demineralized bone
under acidic conditions. Therefore, the effects of epinephr-ine (a- and h-adrenergic agonist) at a concentration of 1 AM
on the expression of mRNA for Int aV, CAII and Cathe K
were examined in osteoclast-like MNCs. As shown in Fig.
2, mRNA levels of Int aV, CAII and Cathe K in osteoclast-
like MNCs were up-regulated by treatment with epinephrine
for 1–6 h, which suggested that the function of osteoclasts
might be directly enhanced by adrenergic stimulation.
3.3. Effects of phenylephrine, epinephrine and isoprenaline
on bone-resorbing activity in osteoclast-like MNCs
Next, the effects of adrenergic agonists, phenylephrine
(a1-adrenergic agonist), epinephrine and isoprenaline (h-
adrenergic agonist) on bone-resorbing activity were exam-
ined in osteoclast-like MNCs by using the calcium phos-
phate-coated disks. Osteoclast-like MNCs were seeded on
the calcium phosphate-coated disks and treated with phenyl-
ephrine, epinephrine and isoprenaline at a concentration of 1
AM for 5 days. As shown in Fig. 3, resorption pits were
clearly larger in osteoclast-like MNCs treated with epinephr-
ine and isoprenaline than in the cells treated with phenyl-
ephrine or the control cells (Fig. 3A). The total area of the
resorption pits was significantly increased by treatment with
epinephrine and isoprenaline, but not by the treatment with
phenylephrine (Fig. 3B). As the potency of epinephrine for
h-AR is lower than that of isoprenaline, epinephrine seems
to enhance less the resorption activity compared with
isoprenaline. In addition, treatment with clonidine (a2-
adrenergic agonist) did not affect the resorbing activity (data
not shown). These results suggested that h2-AR of mature
osteoclasts was involved in resorbing activity, and were well
consistent with the findings of Frediani et al. [10]. They also
demonstrated that catecholamines may act as stimulators of
Fig. 2. Effects of epinephrine on expression of Int aV, CAII and Cathe K.
(A) RT-PCR analysis for mRNA obtained from human osteoclast-like
MNCs treated with epinephrine (1 AM) for 0, 1 and 6 h, and assayed by
RT-PCR using specific primers. DNA size markers (fX174/HaeIII digest)
are shown on the left lane (S). Numbers in parentheses on the right indi-
cate cycles of PCR amplification. Arrow indicates the predicted sizes of
PCR products. GAPDH is a housekeeping gene for internal standard. (B)
The mRNA level of Int aV, CAII and Cathe K was calculated by dividing
the intensity of the Int aV, CAII and Cathe K bands by the intensity of
the GAPDH band as determined by a fluorescent image analyzer. Pooled
data from four independent experiments are expressed as meansF S.E.
(*P< 0.05 and **P < 0.01, statistical difference from control, by Student’s
t-test).
Fig. 3. Effects of adrenergic agonists on resorbing activity of human
osteoclast-like MNCs. (A) Microscopic photograph of von Kossa stained
calcium phosphate-coated disk on which osteoclast-like MNCs were
cultured in the absence (a) or presence of 1 AM phenylephrine (b),
epinephrine (c) and isoprenaline (d) for 5 days. Arrow indicates resorbed pit
by hMNCs. Bar = 0.2 mm. (B) Total pit area was calculated at each
microscopic photograph by counting mesh number inside the pit. Column
and bars are expressed as meansF S.E. (n= 4). (*P < 0.01 and **P < 0.005,
statistical difference from control, by Student’s t-test).
Fig. 4. Effects of adrenergic agonists on actin ring formation in human
osteoclast-like MNCs. Osteoclast-like MNCs placed on cover glass were
cultured in the absence (a) or presence of 1 AM phenylephrine (b),
epinephrine (c) and isoprenaline (d) for 24 h. After culture, osteoclast-like
MNCs were fixed and stained for F-actin with rhodamine-conjugated
phalloidin. Bar = 0.1 mm.
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clonal cell line of human osteoclast precursors. On the other
hand, the physiological roles of a-ARs expressed in osteo-
clast-like MNCs were not clarified.
Osteoclasts are multinuclear bone-resorbing cells that
display structural and functional changes between a resorb-
ing and a nonresorbing/migrating state [7]. In the resorbing
state, osteoclasts recognize bone matrix proteins, adhere to
the bone surface through integrin receptors, and exhibit a
highly polarized cytoplasmic organization with ruffled bor-
ders and clear zones. It is well known that the adhesive site
of osteoclast shows actin rings (a ring formation of F-actin
filaments), which are closely related to bone-resorbing
activity [7,30,31]. Therefore, the effects of adrenergic ago-
nists on actin ring formation were examined in osteoclast-
like MNCs. As shown in Fig. 4, actin rings were faintly
observed in control osteoclast-like MNCs similar to osteo-
clast-like MNCs treated with phenylephrine, which sug-
gested that resorbing activity of those osteoclast-like MNCs
was markedly lowered within 24 h. This finding was
consistent with the evidence that most isolated mature
osteoclasts placed on culture dishes decreased their bone-
resorbing activity within 24 h in the absence of supporting
cells, such as osteoblasts/stromal cells [31]. On the other
hand, actin rings were clearly shown at the peripheral of
osteoclast-like MNCs treated with isoprenaline and epi-
nephrine, which suggested that h-adrenergic agonists act
on osteoclast-like MNCs directly to maintain their bone-
resorbing activity.
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Bone resorption by h-adrenergic stimulation was dem-
onstrated in in vivo and in vitro experiments. In neonatal
mouse calvariae, adrenergic agonists increased cAMP pro-
duction, and in the presence of a phosphodiesterase inhibitor
and an antioxidant, they stimulated bone resorption [5].
Osteoclastic bone resorption consists of multiple steps such
as the differentiation of osteoclast precursors into mono-
nuclear prefusion osteoclasts, the fusion of prefusion osteo-
clasts to form multinucleate osteoclasts, and the activation
of these osteoclasts to resorb bone [7]. Bone-resorbing
factors, such as 1a,25(OH)2D3, parathyroid hormone,
PGE2, interleukin-1a and tumor necrosis factor-a, appear
to act on osteoblasts/stromal cells to induce osteoclasto-
genesis in the mouse bone marrow culture system or the co-
culture system of mouse spleen cells and osteoblasts
through expression of ODF/RANKL [8]. We also demon-
strated that h-adrenergic stimulation induced expression of
mRNA for ODF/RANKL in the mouse osteoblastic cell
line, MC3T3-E1, and induced osteoclastogenesis in the
mouse bone marrow culture system [9]. In the present study,
we showed that both epinephrine and isoprenaline enhanced
bone-resorbing activity of human osteoclast-like MNCs in
the absence of osteoblasts/stromal cells, suggesting that h-
adrenergic agonists not only indirectly stimulate osteoclas-
togenesis via osteoblastic cells but also directly stimulate
bone-resorbing activity of osteoclasts.
In conclusion, we demonstrated that h-adrenergic agonist
could directly stimulate bone-resorbing activity of mature
human osteoclasts.Acknowledgements
This study was partly supported by a grant-in-aid (No.
14571782 to A.T.) from the Ministry of Education, Science,
Sports, and Culture of Japan.References
[1] G. Sisask, A. Bjurholm, M. Ahmed, A. Kreicbergs, The development
of autonomic innervation in bone and joints of the rat, J. Auton. Nerv.
Syst. 59 (1996) 27–33.
[2] A. Bjurholm, A. Kreicbergs, L. Terenius, M. Goldstein, M. Schultz-
berg, Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intesti-
nal polypeptide-immunoreactive nerves in bone and surrounding
tissues, J. Auton. Nerv. Syst. 25 (1988) 119–125.
[3] A. Togari, M. Mogi, M. Arai, S. Yamamoto, Y. Koshihara, Expres-
sion of mRNA for axon guidance molecules, such as semaphorin-III,
netrins and neurotrophins, in human osteoblasts and osteoclasts,
Brain Res. 878 (2000) 204–209.
[4] M. Cherruau, P. Facchinetti, B. Baroukh, J.L. Saffar, Chemical sym-
pathectomy impairs bone resorption in rats: a role for the sympathetic
system on bone metabolism, Bone 25 (1999) 545–551.
[5] R.E. Moore, C.K. Smith II, C.S. Bailey, E.F. Voelkel, A.H. Tashjian
Jr., Characterization of beta-adrenergic receptors on rat and humanosteoblast-like cells and demonstration that beta-receptor agonists can
stimulate bone resorption in organ culture, Bone Miner. 23 (1993)
301–315.
[6] M. Kusuda, T. Oshima, K. Yokota, S. Yamamoto, M. Kumegawa,
Possible induction of fatty acid cyclooxygenase in mouse osteoblastic
cells (MC3T3-E1) by cAMP, Biochim. Biophys. Acta 972 (1988)
339–346.
[7] T. Suda, I. Nakamura, E. Jimi, N. Takahashi, Regulation of osteoclast
function, J. Bone Miner. Res. 12 (1997) 869–879.
[8] N. Takahashi, N. Udagawa, T. Suda, A new member of tumor ne-
crosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates
osteoclast differentiation and function, Biochem. Biophys. Res. Com-
mun. 256 (1999) 449–455.
[9] T. Takeuchi, T. Tsuboi, M. Arai, A. Togari, Adrenergic stimulation of
osteoclastogenesis mediated by expression of osteoclast differentia-
tion factor in MC3T3-E1 osteoblast-like cells, Biochem. Pharmacol.
61 (2001) 579–586.
[10] U. Frediani, L. Becherini, L. Lasagni, A. Tanini, M.L. Brandi, Cat-
echolamines modulate growth and differentiation of human preosteo-
clastic cells, Osteoporos. Int. 6 (1996) 14–21.
[11] K. Tezuka, T. Sato, H. Kamioka, P.J. Nijweide, K. Tanaka, T. Matsuo,
M. Ohta, N. Kurihara, Y. Hakeda, M. Kumegawa, Identification of
osteopontin in isolated rabbit osteoclasts, Biochem. Biophys. Res.
Commun. 186 (1992) 911–917.
[12] P. Chomczynski, N. Sacchi, Single-step method of RNA isolation
by acid guanidinium thiocyanate-phenol – chloroform extraction,
Anal. Biochem. 162 (1987) 156–159.
[13] A. Togari, H. Ichinose, S. Matsumoto, K. Fujita, T. Nagatsu, Multiple
mRNA forms of human GTP cyclohydrolase I, Biochem. Biophys.
Res. Commun. 187 (1992) 359–365.
[14] J.F. Bruno, J. Whittaker, J.F. Song, M. Berelowitz, Molecular cloning
and sequencing of a cDNA encoding a human a1A adrenergic recep-
tor, Biochem. Biophys. Res. Commun. 179 (1991) 1485–1490.
[15] C.S. Ramarao, J.M. Denker, D.M. Perez, R.J. Gaivin, R.P. Riek, R.M.
Graham, Genomic organization and expression of the human a1B-
adrenergic receptor, J. Biol. Chem. 267 (1992) 21936–21945.
[16] A. Hirasawa, K. Horie, T. Tanaka, K. Takagaki, M. Murai, J. Yano, G.
Tsujimoto, Cloning, functional expression and tissue distribution of
human cDNA for the a1C-adrenergic receptor, Biochem. Biophys.
Res. Commun. 195 (1993) 902–909.
[17] B.K. Kobilka, H. Matsui, T.S. Kobilka, T.L. Yang-Feng, U. Francke,
M.G. Caron, R.J. Lefkowitz, J.W. Regan, Cloning, sequencing, and
expression of the gene coding for the human platelet a2-adrenergic
receptor, Science 238 (1987) 650–656.
[18] J.W. Lomasney, W. Lorenz, L.F. Allen, K. King, J.W. Regan, T.L.
Yang-Feng, M.G. Caron, R.J. Lefkowitz, Expansion of the a2-adrener-
gic receptor family: cloning and characterization of a human a2-adre-
nergic receptor subtype, the gene for which is located on chromosome
2, Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 5094–5098.
[19] J.W. Regan, T.S. Kobilka, T.L. Yang-Feng, M.G. Caron, R.J.
Lefkowitz, B.K. Kobilka, Cloning and expression of a human
kidney cDNA for an a2-adrenergic receptor subtype, Proc. Natl.
Acad. Sci. U. S. A. 85 (1988) 6301–6305.
[20] T. Frielle, S. Collins, K.W. Daniel, M.G. Caron, R.J. Lefkowitz, B.K.
Kobilka, Cloning of the cDNA for the human h1-adrenergic receptor,
Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7920–7924.
[21] B.K. Kobilka, T. Frielle, H.G. Dohlman, M.A. Bolanowski, R.A.
Dixon, P. Keller, M.G. Caron, R.J. Lefkowitz, Delineation of the
intronless nature of the genes for the human and hamster h2-
adrenergic receptor and their putative promoter regions, J. Biol.
Chem. 262 (1987) 7321–7327.
[22] L.J. Emorine, S. Marullo, M.M. Briend-Sutren, G. Patey, K. Tate, C.
Delavier-Klutchko, A.D. Strosberg, Molecular characterization of the
human h3-adrenergic receptor, Science 245 (1989) 1118–1121.
[23] M. Ketcham, R.M. Roberts, R.C. Simmen, H.S. Nick, Molecular
cloning of the type 5, iron-containing, tartrate-resistant acid phospha-
tase from human placenta, J. Biol. Chem. 264 (1989) 557–563.
M. Arai et al. / Biochimica et Biophysica Acta 1640 (2003) 137–142142[24] R.E. Kuestner, R.D. Elrod, F.J. Grant, F.S. Hagen, J.L. Kuijper, S.L.
Matthewes, P.J. O’Hara, P.O. Sheppard, S.D. Stroop, D.L. Thompson,
Cloning and characterization of an abundant subtype of the human
calcitonin receptor, Mol. Pharmacol. 46 (1994) 246–255.
[25] C. Forsman, G. Behravan, A. Osterman, B.H. Jonsson, Production of
active human carbonic anhydrase II in E. coli, Acta Chem. Scand.,
Ser. B 42 (1988) 314–318.
[26] J.P. Donahue, N. Sugg, J. Hawiger, The integrin alpha v gene: iden-
tification and characterization of the promoter region, Biochim. Bio-
phys. Acta 1219 (1994) 228–232.
[27] T. Inaoka, G. Bilbe, O. Ishibashi, K. Tezuka, M. Kumegawa, T.
Kokubo, Molecular cloning of human cDNA for cathepsin K: novel
cysteine proteinase predominantly expressed in bone, Biochem. Bio-
phys. Res. Commun. 206 (1995) 89–96.
[28] P. Arcari, R. Martinelli, F. Salvatore, The complete sequence of a fulllength cDNA for human liver glyceraldehyde-3-phosphate dehydro-
genase: evidence for multiple mRNA species, Nucleic Acids Res. 12
(1984) 9179–9189.
[29] Y. Koshihara, S. Kodama, H. Ishibashi, Y. Azuma, T. Ohta, S. Karube,
Reversibility of alendronate-induced contraction in human osteoclast-
like cells formed from bone marrow cells in culture, J. Bone Miner.
Metab. 17 (1999) 98–107.
[30] I. Nakamura, N. Takahashi, T. Sasaki, E. Jimi, T. Kurokawa, T. Suda,
Chemical and physical properties of the extracellular matrix are re-
quired for the actin ring formation in osteoclasts, J. Bone Miner. Res.
11 (1996) 1873–1879.
[31] E. Jimi, I. Nakamura, L.T. Duong, T. Ikebe, N. Takahashi, G.A.
Rodan, T. Suda, Interleukin 1 induces multinucleation and bone-
resorbing activity of osteoclasts in the absence of osteoblasts/stro-
mal cells, Exp. Cell Res. 247 (1999) 84–93.
